Tag: Bristol myers squibb

First approved by the FDA in 2012 for stroke prevention, Eliquis became a blockbuster drug and a central part of a major pharmaceutical collaboration. The partnership responsible for who makes Eliquis medication involves two of the world's largest drug manufacturers, combining their resources to bring the anticoagulant to market.

When the use of Taxol was first approved in 1994, it cost approximately $2,614 per dose, highlighting the significant financial barrier cancer drugs can present. The actual out-of-pocket expense for the chemotherapy drug Taxol varies dramatically based on whether a patient receives the brand-name version or the far cheaper generic paclitaxel, alongside other factors like insurance coverage and available financial aid programs.

First approved by the FDA on **June 20, 2003**, atazanavir (Reyataz) marked a significant advancement in HIV treatment as the first once-daily protease inhibitor for adults. The answer to the question 'when was atazanavir FDA approved?' highlights a key moment in the evolution of antiretroviral therapy and the shift towards more convenient, patient-friendly dosing regimens.

Cases of life-threatening hepatic failure have been reported in patients treated with nefazodone [1.3.3]. This article explores why was nefazodone taken off the market, detailing the safety concerns and the manufacturer's decision to cease production.

In December 1992, the U.S. Food and Drug Administration (FDA) first granted approval for the brand-name drug Taxol (paclitaxel) for the treatment of refractory ovarian cancer. The medication's journey from a rare tree bark to a life-saving chemotherapy, however, began decades earlier, marked by scientific breakthroughs, supply challenges, and significant milestones.